The 20 Best Fibrolamellar Carcinoma Doctors Near Me in Bryan, TX

Ahmed Kaseb is an Oncologist practicing medicine in Houston, Texas. Dr. Kaseb is rated as an Elite provider by MediFind in the treatment of Fibrolamellar Carcinoma. He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Liver Cancer, Fibrolamellar Carcinoma, Cholangiocarcinoma (Bile Duct Cancer), Hepatectomy, and Liver Embolization.

Robert Goldstein, MD, FACS is a Clinical Professor at Texas A&M College of Medicine at Texas A&M Health Science Center, Dallas. He is Medical Director of the Liver and Pancreas Disease Center at the Annette C. and Harold C. Simmons Transplant Institute. He is also Chief of Hebatobilliary Surgery and Director of the General Surgery Residency Program at Baylor University Medical Center, part of Baylor Scott & White Health. Dr. Goldstein's clinical interests include liver cancer, bile duct cancer and bile duct injuries. He provides immediate evaluation and medical management of patients with newly diagnosed benign and cancerous liver lesions. He and a team of transplant and oncologic surgery specialists work together to offer aggressive advanced treatments. With 30 years of experience in a high-volume transplant center, Dr. Goldstein is one of the most practiced hepatobilliary surgeons in the nation. Dr. Goldstein received his medical degree from the University of Tennessee Health Science Center in Memphis. He completed his residency at West Virginia University School of Medicine. He went on to start a transplant fellowship at the University of Pittsburgh and completed the transplant fellowship at Baylor University Medical Center in Dallas where he has dedicated his entire medical career to the care and treatment of liver cancer patients and liver transplant patients. Read more about Dr. Goldstein's publications on PubMed.gov and the Baylor Health Sciences Library. Read more about Dr. Goldstein's publications. Dr. Goldstein has been named one of D Magazine’s Best Docs at least 15 times earning him a place on D Magazine’s Hall of Fame list. Dr. Goldstein has been named one of Texas Monthly's Texas Super Doctors for the past 15 years earning him a place on Texas Monthly's Legacy list. Dr. Goldstein is rated as a Distinguished provider by MediFind in the treatment of Fibrolamellar Carcinoma. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Fibrolamellar Carcinoma, Progressive Familial Intrahepatic Cholestasis Type 2, Progressive Familial Intrahepatic Cholestasis Type 1, Liver Transplant, and Splenectomy. Dr. Goldstein is board certified in Transplant Surgery- American Board Of Surgery/General Surgery, - American Board Of Surgery/General Surgery, General Surgery- American Board Of Surgery/General Surgery, Transplant Surgery- American Board Of Surgery, and General Surgery- American Board Of Surgery.

Ashwini Mehta is a Hepatologist and a Transplant Surgeon practicing medicine in Dallas, Texas. Dr. Mehta is rated as a Distinguished provider by MediFind in the treatment of Fibrolamellar Carcinoma. She is also highly rated in 4 other conditions, according to our data. Her clinical expertise encompasses Fibrolamellar Carcinoma, Ascites, Liver Failure, Hepatitis, and Liver Transplant. Dr. Mehta is board certified in Transplant Hepatology- American Osteopathic Board Of Internal Medicine and Internal Medicine- American Osteopathic Board Of Internal Medicine.

Since she was an intern at the Cleveland Clinic Foundation, Dr. Saira Khaderi has developed a strong interest in hepatology and liver transplantation. During her residency, she was involved in research related to complications of portal hypertension, and in 2006 she was honored with the American Association for the Study of Liver Diseases Travel Scholar Award, an award given to accomplished trainees with potential for a career in academic medicine. After completing her residency, she returned to Houston and continued working in transplant medicine at Methodist Hospital, where she was an active member of the liver and kidney transplant programs. Dr. Khaderi is rated as a Distinguished provider by MediFind in the treatment of Fibrolamellar Carcinoma. She is also highly rated in 12 other conditions, according to our data. Her clinical expertise encompasses Hepatitis, Visceromegaly, Hepatitis C, Enlarged Liver, and Liver Transplant. Dr. Khaderi is currently accepting new patients.

Dr. Orr specializes in Medical Oncology and Hematology with a board certification in Internal Medicine and Medical Oncology.Dr. Orr attended medical school at Vanderbilt University Medical School in Nashville, TN. He then completed an Internal Medicine residency at Vanderbilt University Hospital in Nashville, TN and a Medical Oncology fellowship at the Johns Hopkins Oncology Center in Baltimore, MD.He is a Diplomate of the American Board of Internal Medicine. Dr. Orr is rated as a Distinguished provider by MediFind in the treatment of Fibrolamellar Carcinoma. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Fibrolamellar Carcinoma, Gastric Lymphoma, Myeloproliferative Neoplasms (MPN), and Liver Cancer. Dr. Orr is board certified in Medical Oncology- American Board Of Internal Med/Medical Oncology, Internal Medicine- American Board Of Internal Med, Internal Medicine- American Board Of Internal Medicine, and Medical Oncology- American Board Of Internal Medicine.

Michael Middlebrook is a Radiologist practicing medicine in San Antonio, Texas. Dr. Middlebrook is rated as a Distinguished provider by MediFind in the treatment of Fibrolamellar Carcinoma. He is also highly rated in 27 other conditions, according to our data. His clinical expertise encompasses Intussusception in Children, Ascites, Visceromegaly, Liver Embolization, and Bone Marrow Aspiration.

Marouane Bouchareb is an Interventional Radiologist practicing medicine in Austin, Texas. Dr. Bouchareb is rated as a Distinguished provider by MediFind in the treatment of Fibrolamellar Carcinoma. He is also highly rated in 13 other conditions, according to our data. His clinical expertise encompasses Visceromegaly, Fibrolamellar Carcinoma, Ascites, Bone Marrow Aspiration, and Gastrostomy.

Parvez Mantry is a Hepatologist and a Gastroenterologist practicing medicine in Dallas, Texas. Dr. Mantry is rated as a Distinguished provider by MediFind in the treatment of Fibrolamellar Carcinoma. He is also highly rated in 22 other conditions, according to our data. His clinical expertise encompasses Nonalcoholic Steatohepatitis (NASH), Hepatitis, Liver Failure, Liver Transplant, and Endoscopy. Dr. Mantry is board certified in Gastroenterology- American Board Of Internal Med.

Keith Pettibon is a Radiologist and an Interventional Radiologist practicing medicine in Fort Worth, Texas. Dr. Pettibon is rated as a Distinguished provider by MediFind in the treatment of Fibrolamellar Carcinoma. He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Fibrolamellar Carcinoma, Ascites, Pleurisy, Liver Embolization, and Vertebroplasty. Dr. Pettibon is board certified in Interventional Radiology/Diagnostic Radiology- American Board Of Radiology/Interventional Radiology And Diagnostic Radiology, Interventional Radiology And Diagnostic Radiology- American Board Of Radiology/Interventional Radiology And Diagnostic Radiology, Interventional Radiology And Diagnostic Radiology- American Board Of Radiology, and Diagnostic Radiology- American Board Of Radiology.

Joseph Galati is a Hepatologist practicing medicine in Houston, Texas. Dr. Galati is rated as a Distinguished provider by MediFind in the treatment of Fibrolamellar Carcinoma. He is also highly rated in 20 other conditions, according to our data. His clinical expertise encompasses Hepatitis, Liver Failure, Hepatitis C, Liver Transplant, and Endoscopy. Dr. Galati is board certified in Hepatology and Gastroenterology.

Henry Xiong is an Oncologist practicing medicine in Fort Worth, Texas. Dr. Xiong is rated as a Distinguished provider by MediFind in the treatment of Fibrolamellar Carcinoma. He is also highly rated in 25 other conditions, according to our data. His clinical expertise encompasses Fibrolamellar Carcinoma, Liver Cancer, Colorectal Cancer, and Familial Colorectal Cancer. Dr. Xiong is board certified in Medical Oncology- American Board Of Internal Med/Medical Oncology and Medical Oncology- American Board Of Internal Medicine.

Dr. Tannaz Armaghany is Assistant Professor of Medicine-Hematology and Oncology at the Dan L Duncan Comprehensive Cancer Center at Baylor College of Medicine.Dr. Armaghany’s professional interests include: gastrointestinal medical oncology, neuroendocrine tumors, hepatocellular carcinoma, and hepatobiliary cancers.Dr. Armaghany received her medical degree from Tabriz University in Tabriz, Iran and completed her residency at Cook County Hospital in Chicago, Ill. She also completed fellowships in hematology and medical oncology at Louisiana State University Health in Shreveport, La. and integrative medicine at Arizona State University in Tucson, Ariz.Dr. Armaghany is board-certified in Medical Oncology, Hematology, and Internal Medicine from the American Board of Internal Medicine.Dr. Armaghany serves as President of the Texas branch of the Iranian American Medical Association. She is also a member of American College of Clinical Oncology, American Society of Hematology, North American Neuroendocrine Tumor Society, SWOG Cancer Research Network, Harris County Medical Society, International Society of Liver Cancer, and the Texas Medical Association. Dr. Armaghany is rated as an Advanced provider by MediFind in the treatment of Fibrolamellar Carcinoma. She is also highly rated in 9 other conditions, according to our data. Her clinical expertise encompasses Neuroendocrine Tumor, Fibrolamellar Carcinoma, Gallbladder Cancer, and Gallbladder Adenocarcinoma. Dr. Armaghany is currently accepting new patients.

"Dr. Beecherl is a Clinical Associate Professor at Texas A&M College of Medicine at Texas A&M Health Science Center, Dallas. Dr. Beecherl is a board-certified general surgeon with a focus on hepato-biliary and pancreatic surgery, islet autotransplantation and gastrointestinal oncologic surgery. He has practiced in Dallas since finishing his fellowship training in 1999. Prior to moving to Baylor University Medical Center, part of Baylor Scott & White Health, in Dallas, he practiced at Presbyterian Hospital of Dallas serving in several leadership positions including the Executive Committee of the Medical Board and seven years as Chairman of the Department of General Surgery. He has been named one of the ""Best Doctors in Dallas"" by D Magazine perennially since 2001. He has also been recognized as a ""Texas Super Doctor"" by Texas Monthly Magazine for the last several consecutive years. Dr. Beecherl received his Bachelor of Science degree in Chemical Engineering from the University of Texas, at Austin in 1986, his Masters of Science in Anatomy from Tulane University Graduate School in 1991, and his Doctorate of Medicine from Tulane University Medical Center in 1991. Dr. Beecherl started his post-graduate training in Dallas as a surgical intern at Parkland Memorial Hospital in 1991. He then trained for six years at the University of Texas Southwestern Medical Center which included two years of laboratory research and four years of residency which he finished in 1998 as the Administrative Surgical Chief Resident of Parkland. His last year of training was a fellowship in Hepato-Biliary and Pancreatic Surgery at the Toronto General Hospital in Toronto, Ontario. After completing his fellowship, Dr. Beecherl returned to Dallas and was a founding partner of Southwest General Surgery Associates. In 2016 he moved to Baylor's Simmons Transplant Institute and serves as the Director of Islet Autotransplantation. Dr. Beecherl is a Fellow of the American College of Surgeons, a Diplomat of the American Board of Surgery, and a member of Dallas County Medical Society, the Texas Medical Society, the Parkland Surgical Society, and the American Hepato-Biliary and Pancreatic Association. Dr. Beecherl is a native of Dallas who stays active outside the hospital raising four children with his wife, Susan, and by serving on several civic, church, and foundation boards. See Dr. Beecherl's Publications here. Read more about Dr. Beecherl's publications on PubMed.gov and the Baylor Health Sciences Library . Dr. Beecherl has been named one of Texas Monthly's Texas Super Doctors for the past 20 years earning him a place on Texas Monthly's 20 Years Legacy list.". Dr. Beecherl is rated as an Advanced provider by MediFind in the treatment of Fibrolamellar Carcinoma. He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Hereditary Pancreatitis, Childhood Pancreatitis, Acute Pancreatitis, Islet Cell Transplantation, and Pancreatectomy. Dr. Beecherl is board certified in Transplant Surgery- American Board Of Surgery/General Surgery, Transplant Surgery- American Board Of Surgery, and General Surgery- American Board Of Surgery.

Jason Moss is a Radiologist and an Interventional Radiologist practicing medicine in Dallas, Texas. Dr. Moss is rated as an Advanced provider by MediFind in the treatment of Fibrolamellar Carcinoma. He is also highly rated in 18 other conditions, according to our data. His clinical expertise encompasses Ascites, Bile Duct Obstruction, Jaundice, Liver Embolization, and Bone Marrow Aspiration. Dr. Moss is board certified in Interventional Radiology/Diagnostic Radiology- American Board Of Radiology/Interventional Radiology And Diagnostic Radiology, Interventional Radiology And Diagnostic Radiology- American Board Of Radiology/Interventional Radiology And Diagnostic Radiology, and Interventional Radiology And Diagnostic Radiology- American Board Of Radiology.

Chet Rees is a Radiologist and an Interventional Radiologist practicing medicine in Dallas, Texas. He has been practicing medicine for over 44 years. Dr. Rees is rated as an Advanced provider by MediFind in the treatment of Fibrolamellar Carcinoma. He is also highly rated in 2 other conditions, according to our data. His clinical expertise encompasses Ascites, Fibrolamellar Carcinoma, Angiosarcoma of the Liver, Bone Marrow Aspiration, and Liver Embolization. Dr. Rees is board certified in Interventional Radiology And Diagnostic Radiology- American Board Of Radiology/Interventional Radiology And Diagnostic Radiology, Diagnostic Radiology- American Board Of Radiology/Diagnostic Radiology, Diagnostic Radiology- American Board Of Radiology, and Interventional Radiology And Diagnostic Radiology- American Board Of Radiology.

Marco Cura is a Radiologist practicing medicine in Dallas, Texas. Dr. Cura is rated as an Advanced provider by MediFind in the treatment of Fibrolamellar Carcinoma. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Ascites, Pleural Effusion, Fibrolamellar Carcinoma, Liver Embolization, and Gastrostomy. Dr. Cura is board certified in Interventional Radiology And Diagnostic Radiology- American Board Of Radiology/Interventional Radiology And Diagnostic Radiology and Interventional Radiology And Diagnostic Radiology- American Board Of Radiology.

Dr. Testa is a Clinical Professor at Texas A&M College of Medicine at Texas A&M Health Science Center, Dallas. He is Chief of Abdominal Transplant at Baylor University Medical Center, part of Baylor Scott & White Health and Chairman of the Annette C. and Harold C. Simmons Transplant Institute. He specializes in living donor liver transplantation and is the principal investigator of the Uterine Transplant Clinical Trial that resulted in the first U.S. birth of a baby following uterine transplant. Dr. Testa was honored in 2018 as one of TIME Magazine's Top 100 for leading the medical team that performed the first successful uterus transplants in the nation. Dr. Testa is a graduate of t he University of Padova Medical School in Italy. After graduating cum laude, he completed a residency in general surgery at the same university. He went on to complete a general surgery residency at the University of Chicago and then a fellowship in abdominal organ transplant at Baylor University Medical Center in Dallas. Later at the University of Essen in Germany, he was instrumental in starting the first adult living donor liver transplant program in Europe. Dr. Testa returned to the U.S. in 2001, where he served as Director of Liver Transplant at the University of Illinois. In 2005, he moved to the University of Chicago where he rose to the rank of Professor of Surgery and served as Director of Liver Transplant and Hepatobilliary Surgery. Read more about Dr. Testa's publications on PubMed.gov and the Baylor Health Sciences Library. Dr. Testa returned to Baylor University Medical Center in 2011 to lead the Living Donor Liver Program. He became Chief of Abdominal Transplant for the Annette C. and Harold C. Simmons Transplant Institute in 2017. Dr. Testa is author or co-author of more than 160 publications and several book chapters. He is a recognized authority in Uterus Transplantation and Living Donor Liver Transplantation. His other interests include complex liver surgery of benign and malignant diseases. Read more about Dr. Testa Dr. Testa has been named one of Texas Monthly's Texas Super Doctors for over 10 years earning him a place on Texas Monthly's Hall of Fame list. Dr. Testa is rated as an Advanced provider by MediFind in the treatment of Fibrolamellar Carcinoma. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Liver Failure, Hepatitis, Fibrolamellar Carcinoma, Liver Transplant, and Hysterectomy. Dr. Testa is board certified in Transplant Surgery- American Board Of Surgery/General Surgery and Transplant Surgery- American Board Of Surgery.

Dr. McDonald attended medical school at the University of New Mexico School of Medicine. He then completed a Radiology residency at Texas A&M University Health Science Center College of Medicine - Baylor Scott & White Health before fellowship training in Vascular and Interventional Radiology at Massachusetts General Hospital in Boston. He is the Director of the Division of Interventional Radiology at Baylor Scott & White in Central Texas. Dr. Mcdonald is rated as an Advanced provider by MediFind in the treatment of Fibrolamellar Carcinoma. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses WT1-Related Wilms Tumor Syndromes, Ascites, Peripheral Artery Disease, Gastrostomy, and Bone Marrow Aspiration. Dr. Mcdonald is board certified in Interventional Radiology And Diagnostic Radiology- American Board Of Radiology.

Prasun K. Jalal, M.D is Assistant Professor of Surgery in the Division of Abdominal Transplantation of the Michael E. DeBakey Department of Surgery and in the Department of Medicine, Section of Gastroenterology and Hepatology, at Baylor College of Medicine. Dr. Jalal is board certified in gastroenterology, internal medicine and transplant hepatology. Dr. Jalal earned his medical degree from Postgraduate Institute of Medical Education and Research, Chandigarh, India. His extensive training includes training in gastroenterology and hepatology at St. James Hospital in Leeds, England. He completed a fellowship in gastroenterology at Long Island Jewish Medical Center-Albert Einstein College of Medicine, New York and in transplant hepatology at Mount Sinai School of Medicine, New York. Dr. Jalal's clinical interests include viral hepatitis, liver transplant, liver cancer and autoimmune hepatitis. Dr. Jalal is rated as an Advanced provider by MediFind in the treatment of Fibrolamellar Carcinoma. He is also highly rated in 26 other conditions, according to our data. His clinical expertise encompasses Hepatitis, Esophageal Varices, Hepatitis A, Liver Transplant, and Hepato-Pancreato-Biliary Surgery. Dr. Jalal is currently accepting new patients.

Dr. Suzie Lee is a Clinical Assistant Professor at Texas A&M College of Medicine at Texas A&M Health Science Center, Dallas. She is a multi-organ transplant surgeon, performing liver, kidney and pancreas transplants. Her professional interests include biliary disease and complex gastrointestinal issues of the pancreas and liver. As an accomplished hepatopancreatic biliary surgeon, she provides patients with innovative treatment and surgical options for liver, pancreas and bile duct cancer. After earning her medical degree from University of Pittsburgh School of Medicine, she completed her residency in general surgery at Vanderbilt University in Nashville, TN. She went on to complete a fellowship in abdominal transplant surgery at Washington University School of Medicine in St. Louis. Before pursuing medicine, Dr. Lee served in the Peace Corps in Mali, West Africa and worked as a book publicist in New York. Dr. Lee is active in the International Hepato-Pancreato Biliary Association and the American Society of Transplant Surgeons. When she is not operating, Dr. Lee enjoys exploring Texas and experiencing new adventures with her husband and children. Dr. Lee is rated as an Advanced provider by MediFind in the treatment of Fibrolamellar Carcinoma. She is also highly rated in 1 other condition, according to our data. Her clinical expertise encompasses Fibrolamellar Carcinoma, Chronic Antibody-Mediated Rejection, Visceromegaly, Kidney Transplant, and Simultaneous Pancreas Kidney Transplant. Dr. Lee is board certified in Transplant Surgery- American Board Of Surgery/General Surgery, Transplant Surgery- American Board Of Surgery, and General Surgery- American Board Of Surgery.